Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the efficacy of boceprevir in triple combination therapy with peginterferon alfa-2a and ribavirin given as response guided treatment regimen (total of 28 or 48 treatment weeks) on the clearance of HCV 12 weeks after treatment end (sustained virological response) in treatment-naïve patients with genotype 1 chronic HCV infection
Inclusion criteria
- Genotype 1 CHC virus infection